We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.32B
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+30.92%
3 Year Est. Return
+106.56%
5 Year Est. Return
+134.28%
10 Year Est. Return
+431.49%
AUM
$1.91B
AUM Growth
-$58.7M
Cap. Flow
-$6.54M
Cap. Flow %
-0.34%
Top 10 Hldgs %
39.91%
Holding
252
New
15
Increased
80
Reduced
73
Closed
17

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$5.48M
2
MS icon
Morgan Stanley
MS
+$5.37M
3
PFE icon
Pfizer
PFE
+$4.76M
4
FAST icon
Fastenal
FAST
+$4.66M
5
TGT icon
Target
TGT
+$4.36M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.8M
3
DIS icon
Walt Disney
DIS
+$8.48M
4
LMT icon
Lockheed Martin
LMT
+$6.84M
5
TRV icon
Travelers Companies
TRV
+$3.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.07%
2 Technology 21.25%
3 Healthcare 12.53%
4 Financials 11.18%
5 Consumer Discretionary 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTU icon
51
Intuit
INTU
$87.1B
$10.8M 0.57%
22,424
-5,894
-21% -$3.02M
NYT icon
52
New York Times
NYT
$12.2B
$10.3M 0.54%
223,713
+95,439
+74% +$4.14M
NEE icon
53
NextEra Energy
NEE
$181B
$9.7M 0.51%
114,449
+2,043
+2% +$164K
NKE icon
54
Nike
NKE
$63.3B
$9.62M 0.5%
71,467
+8,185
+13% +$1.15M
PFE icon
55
Pfizer
PFE
$143B
$9.61M 0.5%
185,669
+91,816
+98% +$4.76M
TGT icon
56
Target
TGT
$67.8B
$9.58M 0.5%
45,162
+20,142
+81% +$4.36M
FISV
57
Fiserv Inc
FISV
$29B
$9.05M 0.48%
89,289
-3,500
-4% -$354K
ADP icon
58
Automatic Data Processing
ADP
$107B
$9.02M 0.47%
39,640
+353
+0.9% +$75.6K
CTSH icon
59
Cognizant
CTSH
$24.9B
$9.02M 0.47%
100,537
+14,167
+16% +$1.24M
COST icon
60
Costco
COST
$423B
$8.71M 0.46%
15,118
-857
-5% -$450K
GRMN
61
Garmin
GRMN
$58.8B
$8.7M 0.46%
73,313
+3,397
+5% +$409K
ACN icon
62
Accenture
ACN
$101B
$8.46M 0.44%
25,100
+5,461
+28% +$1.84M
CMI icon
63
Cummins
CMI
$89.5B
$8.33M 0.44%
40,628
+489
+1% +$106K
GIS icon
64
General Mills
GIS
$19.2B
$8.16M 0.43%
120,491
-24,250
-17% -$1.63M
COF icon
65
Capital One
COF
$134B
$8.1M 0.42%
61,684
– –
GILD icon
66
Gilead Sciences
GILD
$163B
$7.94M 0.42%
133,543
+12,962
+11% +$829K
SYK icon
67
Stryker
SYK
$131B
$7.89M 0.41%
29,511
-386
-1% -$99.9K
GPN icon
68
Global Payments
GPN
$23.6B
$7.75M 0.41%
56,653
+234
+0.4% +$32.7K
HPQ icon
69
HP
HPQ
$24.8B
$7.62M 0.4%
209,771
+61,130
+41% +$2.26M
AMT icon
70
American Tower
AMT
$80.6B
$7.55M 0.4%
30,054
-5,098
-15% -$1.24M
ADI icon
71
Analog Devices
ADI
$176B
$7.48M 0.39%
45,260
+48
+0.1% +$7.78K
BMY icon
72
Bristol-Myers Squibb
BMY
$134B
$7.43M 0.39%
101,722
-175,510
-63% -$11.8M
CL icon
73
Colgate-Palmolive
CL
$71.6B
$6.93M 0.36%
91,409
-700
-0.8% -$55.4K
LIN icon
74
Linde
LIN
$221B
$6.76M 0.35%
21,160
-313
-1% -$96.8K
CAT icon
75
Caterpillar
CAT
$382B
$6.59M 0.35%
29,593
+5,961
+25% +$1.25M
1 2
3
4 5

Similar funds

HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.32B AUM 27.83% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return

Cullinan Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Cullinan Associates held 252 positions worth $1.91B, down 3% from $1.96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q1 2022 filing shows 15 new, 80 increased, 73 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 14,000 shares worth $5.75M. The largest sale was Walmart Inc, an estimated $14.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q1 2022 buy was West Pharmaceutical: 14,000 shares worth $5.75M.
  • Cullinan Associates added most to Morgan Stanley in Q1 2022, an estimated $5.37M increase.
  • Cullinan Associates's biggest Q1 2022 reduction was Walmart Inc, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Vontier in Q1 2022, selling an estimated $758K.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.91B portfolio in Q1 2022.
  • Cullinan Associates opened 15 new positions and closed 17 in Q1 2022.
  • Cullinan Associates's portfolio value fell 3% quarter-over-quarter to $1.91B.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.